Biocartis is an innovative diagnostics company committed to revolutionize molecular testing with its unique proprietary IdyllaTM platform. Biocartis provides next generation diagnostic solutions, aimed at improving clinical practice for the benefit of patients, clinicians, payers and the healthcare industry, with a focus in oncology which represents the fastest growing segment of the MDx market worldwide.
